美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant

0.0900

+0.019026.76%

成交量：1,150.00

成交额：102.56

市值：36.94万

市盈率：- -

高：0.0900

开：0.0900

低：0.0900

收：0.0710

52周最高：0.1560

52周最低：0.0301

股本：410.45万

流通股本：410.45万

量比：2.46

换手率：0.03%

股息：- -

股息率：- -

净资产收益率：-127.46%

总资产收益率：-71.91%

市净率：-0.10

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

60度制药宣布扩大使用临床试验中所有患者经他非诺喹治疗后巴贝斯虫病痊愈

60 Degrees Pharmaceuticals携手Runway Health为国际旅行者提供疟疾预防药物Arakoda®直供服务

60度制药公司赞助研究显示：北卡罗来纳州立大学同行评审发现24%慢性疲劳患者存在巴贝西虫感染

60 Degrees Pharmaceuticals 宣布 B-Free 慢性巴贝斯病研究的临床试验中心已开放病人入组，地点位于西奈山伊坎医学院

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/SXTPW"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SXTPW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SXTPW\",,,,,undefined,":{"symbol":"SXTPW","market":"US","secType":"STK","nameCN":"60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant","latestPrice":0.09,"timestamp":1776196800000,"preClose":0.071,"halted":0,"volume":1150,"delay":0,"changeRate":0.267605633802817,"floatShares":4104469,"shares":4104469,"eps":0,"marketStatus":"已收盘","change":0.019,"latestTime":"04-14 16:00:00 EDT","open":0.09,"high":0.09,"low":0.09,"amount":102.56245,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1776240000000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":0.071,"volumeRatio":2.460418},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SXTPW\",,,,,undefined,":{"symbol":"SXTPW","floatShares":4104469,"roa":"-71.91%","roe":"-127.46%","lyrEps":0,"volumeRatio":2.460418,"shares":4104469,"dividePrice":0,"high":0.09,"amplitude":0,"preClose":0.071,"low":0.09,"week52Low":0.0301,"pbRate":"-0.10","psRate":"0.80","week52High":0.156,"institutionHeld":0,"latestPrice":0.09,"eps":0,"divideRate":0,"volume":1150,"delay":0,"ttmEps":0,"open":0.09,"prevYearClose":0.0628,"prevWeekClose":0.071,"prevMonthClose":0.0501,"prevQuarterClose":0.0501,"fiveDayClose":0.0501,"twentyDayClose":0.1,"sixtyDayClose":0.055},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SXTPW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SXTPW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SXTPW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SXTPW\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1166654655","title":"60度制药宣布扩大使用临床试验中所有患者经他非诺喹治疗后巴贝斯虫病痊愈","url":"https://stock-news.laohu8.com/highlight/detail?id=1166654655","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166654655?lang=zh_cn&edition=fundamental","pubTime":"2026-03-11 19:24","pubTimestamp":1773228251,"startTime":"0","endTime":"0","summary":"在近期开展的扩大使用临床试验中，60度制药公司宣布，所有接受他非诺喹治疗的巴贝斯虫病患者均已实现临床痊愈。这一突破性进展为罕见寄生虫病的治疗提供了新的可能性，也标志着该创新疗法的有效性得到进一步验证。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","SXTPW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111655792","title":"60 Degrees Pharmaceuticals携手Runway Health为国际旅行者提供疟疾预防药物Arakoda®直供服务","url":"https://stock-news.laohu8.com/highlight/detail?id=1111655792","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111655792?lang=zh_cn&edition=fundamental","pubTime":"2026-01-22 21:02","pubTimestamp":1769086950,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals与Runway Health达成战略合作，将共同为国际旅行者开辟Arakoda疟疾预防药物的直接获取渠道。该合作旨在通过数字化健康平台，为出境人员提供便捷的疟疾预防解决方案。此次合作将整合60 Degrees Pharmaceuticals在热带病防治领域的专业优势与Runway Health的创新医疗服务平台，确保旅行者能够及时获得经临床验证的疟疾预防药物。Arakoda作为美国FDA批准的新型疟疾预防药物，其便捷的用药方案特别适合长期跨境旅行者需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP","SXTPW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145415013","title":"60度制药公司赞助研究显示：北卡罗来纳州立大学同行评审发现24%慢性疲劳患者存在巴贝西虫感染","url":"https://stock-news.laohu8.com/highlight/detail?id=1145415013","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145415013?lang=zh_cn&edition=fundamental","pubTime":"2025-12-29 21:02","pubTimestamp":1767013374,"startTime":"0","endTime":"0","summary":"一项由60度制药公司资助、在北卡罗来纳州立大学开展的同行评审研究揭示，在表现为慢性疲劳症状的患者群体中，巴贝西虫感染的检出率高达24%。该研究成果为慢性疲劳综合征与寄生虫感染之间的潜在关联提供了新的临床证据。\n研究数据表明，近四分之一长期受困于不明原因疲劳的患者，其症状可能与巴贝西虫属原虫感染存在病理学联系。这一发现不仅为慢性疲劳的病因诊断开辟了新视角，也可能推动相关靶向治疗方案的开发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP","SXTPW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104126707","title":"60 Degrees Pharmaceuticals 宣布 B-Free 慢性巴贝斯病研究的临床试验中心已开放病人入组，地点位于西奈山伊坎医学院","url":"https://stock-news.laohu8.com/highlight/detail?id=1104126707","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104126707?lang=zh_cn&edition=fundamental","pubTime":"2025-11-21 21:01","pubTimestamp":1763730076,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals 宣布 B-Free 慢性巴贝斯病研究的临床试验中心现已开放病人入组，地点位于西奈山伊坎医学院。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTPW","BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SXTPW\",params:#limit:6,delay:false,,,undefined,":[]}}